Post the onset of the COVID-19 pandemic, mRNA therapeutics and vaccines have garnered significant attention as they have evolved as a revolutionary novel drug class for the treatment of COVID-19, as well as several other diseases, such as infectious diseases, oncological disorders, genetic
mRNA therapeutics and vaccines have emerged as a promising alternative to conventional treatment approaches. During our research, we were able to identify more than 195 mRNA therapeutics and vaccines that have either been marketed or are being developed in clinical, preclinical and discovery stages for the treatment of various diseases. Driven by the growing interest of various stakeholders and encouraging clinical research results, the overall mRNA therapeutics and mRNA vaccines market is anticipated to witness consistent growth, till 2035.
To request a sample copy / brochure of this report, please visit
https://www.rootsanalysis.com/reports/mrna-therapeutics-and-vaccines-market/request-sample.html
Furthermore, these drug candidates can be used to develop precise and individualized therapies that allow patients to produce therapeutic proteins in their own bodies. It is worth highlighting that there is a significant rise in the interest of stakeholders in mRNA vaccines domain segment; this can be validated by the increase in partnership and funding activity within this domain.
Given the numerous benefits of mRNA therapeutics and the increased demand for vaccines as a result of the recent COVID-19 pandemic, we believe that this market will experience significant growth in the near future. During our research, we came across around 180 ongoing and planned clinical trials focused on mRNA therapeutics and vaccines. There was a steady increase (CAGR of 66%) in the number of clinical trials registered for the evaluation of mRNA-based drugs, during the period 2017-2021. This can be attributed to the incessant efforts of several industry players that are actively evaluating mRNA therapies for the treatment of a myriad of disease indications. It is also worth highlighting that 47 trials were registered in 2022.
For additional details, please visit
https://www.rootsanalysis.com/reports/mrna-therapeutics-and-vaccines-market.html or email [email protected]
You may also be interested in the following titles:
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector.
Contact:
Ben Johnson
+1 (415) 800 3415
ENTERTAINMENT
BUSINESS
NEWS
TECHNOLOGY
BLOCKCHAIN
COVID-19
NATIONAL
WORLD
SPORTS
YOUTUBE
TRAVEL
POLITICS
CONSERVATIVE VIEW
LIBERAL VIEW
DANCE STYLE
FASHION
LIFESTYLE
MUSIC STYLE
INDIAN CUISINE
FESTIVALS IN INDIA
FEMALE CLOTHING
SEASONS
MARRIAGES
ANIMALS
HUMOR
SCIENCE
LIFE STYLE
CELEBRITY
RECIPES
DESIGN
COMPUTER SCIENCE
PHOTOGRAPHY
WEATHER
HEALTH EATING
WOMENS NEWS
BEAUTY
MINDFULNESS
JOB CONSULTANCY
EDUCATION
TUTOR
RESTAURANT
BAR & CAFES
TRAVEL & EVENTS
NEWS & POLITICS
CARS & VEHICLES
ECONOMICS & TRADE
PETS & ANIMALS
GAMING
MOVIES & ANIMATION
PROPERTY
HOME & GARDEN
GIFTS & OCCASIONS
BEAUTY PRODUCTS & SERVICES
BABY & CHILDREN'S PRODUCTS
MANAGEMENT BINARY
Other